RESUMO
A 5 yr old castrated male domestic longhair was examined because of left-sided facial swelling and epistaxis. Head computed tomography with contrast identified a mass within the left nasal cavity and multifocal regions of nasal bone osteolysis. Histopathology of nasal mass biopsies and cytology of the facial swelling revealed pyogranulomatous inflammation due to Blastomyces dermatitidis. The cat experienced resolution of clinical signs following 8 mo of treatment with itraconazole. Although rare, clinicians should include blastomycosis on the differential diagnoses list of infectious causes for feline nasal disease if within an endemic area.
Assuntos
Blastomicose , Doenças do Gato , Gatos , Masculino , Animais , Blastomicose/complicações , Blastomicose/diagnóstico , Blastomicose/tratamento farmacológico , Blastomicose/veterinária , Epistaxe/etiologia , Epistaxe/veterinária , Epistaxe/tratamento farmacológico , Blastomyces , Itraconazol/uso terapêutico , Cavidade Nasal , Antifúngicos/uso terapêutico , Doenças do Gato/diagnóstico , Doenças do Gato/tratamento farmacológicoRESUMO
A 14-year-old cat presented with right-sided epistaxis, right facial swelling, hyporexia, and sneezing. A right nasal mass was diagnosed based on dental radiography and computed tomography (CT), and nasal angiofibroma was diagnosed based on histopathology. Treatment consisted of stereotactic body radiation therapy in three consecutive daily doses. Self-limiting grade 3 oral mucositis developed which resolved within 6 weeks. Recheck CT 169 days after treatment confirmed a partial response by RECIST(1) based on digital CT measurements . Disease progression was confirmed on CT 642 days after treatment, per RECIST criteria, with the longest tumor diameter measuring 3.4 cm.
Assuntos
Angiofibroma , Doenças do Gato , Neoplasias de Cabeça e Pescoço , Gatos , Animais , Angiofibroma/radioterapia , Angiofibroma/cirurgia , Angiofibroma/veterinária , Neoplasias de Cabeça e Pescoço/veterinária , Nariz/patologia , Epistaxe/veterinária , Tomografia Computadorizada por Raios X/veterinária , Doenças do Gato/diagnóstico por imagem , Doenças do Gato/radioterapiaRESUMO
OBJECTIVE: To describe a case of tracheal injury secondary to gunshot trauma in a rhinoceros. ANIMALS: 5-year-old female white rhinoceros (Ceratotherium simum). CLINICAL PRESENTATION, PROGRESSION, AND PROCEDURES: The rhinoceros was found alive with an apparent bullet entry wound cranial to the left shoulder. The rhinoceros was agitated and had bilateral epistaxis and increased respiratory noise. Immobilization of the animal facilitated closer examination and initiation of medical therapy. Radiographs obtained of the neck region at this first examination were nondiagnostic. Subsequent immobilization events allowed for further diagnostics and treatment. TREATMENT AND OUTCOME: Initial treatment included a broad-spectrum antibiotic and a corticosteroid. Five days following the injury, the rhinoceros was considered stable, and the animal was immobilized to investigate the cause of the epistaxis and respiratory signs. Tracheoscopy revealed a full-thickness penetrating wound in the mid to caudal region of the trachea, and the surface of a metallic projectile was viewed within the wound. Medical treatment was continued and the rhinoceros was managed conservatively. At 14 days, radiographs of the neck made with a more powerful unit revealed tissue emphysema dorsal to the trachea. A subsequent tracheoscopy 54 days after injury revealed a granulated wound. Follow-up at 4 years after injury determined that the rhinoceros was reported to be behaving normally and had successfully calved. CLINICAL RELEVANCE: Gunshot wounds associated with poaching are a prevalent problem in rhinoceros in Africa. Although more aggressive therapy including surgery may likely be considered in zoo or domestic animals, limited conservative treatment was successful in this wild-managed rhinoceros.
Assuntos
Ferimentos por Arma de Fogo , Feminino , Animais , Ferimentos por Arma de Fogo/complicações , Ferimentos por Arma de Fogo/veterinária , Epistaxe/veterinária , Antibacterianos , Animais Domésticos , PerissodáctilosAssuntos
Doenças do Cão , Epistaxe , Cães , Feminino , Animais , Epistaxe/etiologia , Epistaxe/veterinária , Espirro , Doenças do Cão/diagnósticoRESUMO
OBJECTIVE: To describe the periprocedural use of a lyophilized platelet product during rhinoscopic diagnosis and treatment of sinonasal aspergillosis in a Greater Swiss Mountain Dog with a P2Y12 platelet receptor disorder. CASE SUMMARY: After the development of severe epistaxis, a Greater Swiss Mountain Dog was diagnosed with thrombopathia secondary to a P2Y12 receptor gene mutation. Concurrent primary nasal disease was also suspected due to persistent mucopurulent nasal discharge. One month after the initial presentation for epistaxis, the dog was readmitted for workup of nasal disease. Computed tomography of the head showed turbinate lysis and regional lymphadenopathy. Because of concern for a high risk of bleeding in a thrombopathic patient subjected to rhinoscopy and nasal biopsies, a lyophilized platelet product was administered prior to the procedure. Rhinoscopic exam revealed fungal plaques consistent with Aspergillus spp. that were later confirmed on fungal culture to be Aspergillus fumigatus. Rhinoscopic biopsies were performed as well as debridement of the fungal plaques, followed by topical administration of clotrimazole solution. Bleeding was minimal during and after the procedure, and the dog recovered uneventfully. NEW OR UNIQUE INFORMATION PROVIDED: This is the first report of the prophylactic use of lyophilized platelets in a thrombopathic patient undergoing an invasive procedure with potential for significant hemorrhage. Minimal bleeding occurred during the procedure, suggesting that lyophilized platelets could be used for the prevention of bleeding in thrombopathic patients undergoing invasive procedures.
Assuntos
Aspergilose , Doenças do Cão , Doenças Nasais , Cães , Animais , Epistaxe/veterinária , Plaquetas , Aspergilose/diagnóstico , Aspergilose/tratamento farmacológico , Aspergilose/veterinária , Doenças Nasais/diagnóstico , Doenças Nasais/microbiologia , Doenças Nasais/patologia , Doenças Nasais/veterinária , Mutação , Doenças do Cão/diagnóstico , Doenças do Cão/tratamento farmacológico , Doenças do Cão/microbiologiaRESUMO
Canine leishmaniasis is a parasitic zoonosis mainly caused by L. infantum; an obligate intracellular protozoan transmitted by haematophagous insects of the genus Phlebotomus, which affects dogs and wild canids. The clinical implications of this disease are highly variable, since infected animals may remain asymptomatic (absence of observable clinical signs) or present a wide spectrum of clinical alterations and degrees of severity, including the death of the animal. Symptoms such as lymphadenomegaly, alopecia, weight loss, keratoconjunctivitis and onychogryphosis are usually the first diagnostic reference available. The objectives of this study are to evaluate the validity (sensitivity, specificity and likelihood ratios) and diagnostic utility (pre-test probability) of the clinical signs commonly associated with canine leishmaniasis based on the prevalence in the area and to explore the combination of symptoms that best predicts the diagnosis of canine leishmaniasis. It is a matched case-control study in the canine population of southern Spain based on the comparison of the findings collected in the clinical history and the results of the LeisSCAN quantitative ELISA. A total of 39 cases and 78 controls were analysed. Approximately 80% of the infected animals showed signs compatible with the disease. The most frequent alterations were cutaneous (64.1%), systemic (51.3%) and oculo-nasal (30.7%). The most useful signs to support this diagnosis were alopecia and epistaxis (LR+ 6.69 and 6.0, respectively) (pre-test leishmaniasis probability is ≥70% for prevalence ≥28% when alopecia or epistaxis is present), followed by lameness (LR+ 5.0). The combinations of signs that showed greater validity were alopecia with hyperkeratosis of the snout and alopecia with onychogryphosis (LR+ > 10). None of the observed signs or their combinations resulted useful to rule out the diagnosis (LR- 0.55 to 1.15). The results found show notable differences in the diagnostic value of the clinical signs, individually and in combination, so we believe that medical decisions should be based on their diagnostic validity (LR+) and the estimation of the pre-test and post-test probability.
Assuntos
Doenças do Cão , Leishmania infantum , Leishmaniose , Phlebotomus , Animais , Cães , Epistaxe/veterinária , Estudos de Casos e Controles , Doenças do Cão/diagnóstico , Doenças do Cão/epidemiologia , Doenças do Cão/parasitologia , Leishmaniose/diagnóstico , Leishmaniose/epidemiologia , Leishmaniose/veterinária , Anticorpos AntiprotozoáriosRESUMO
CASE DESCRIPTION: A 4-year-old spayed female French Bulldog was referred for treatment of a suspected right-sided nasal angiofibroma associated with a 4-month history of unilateral nasal discharge and stertor. CLINICAL FINDINGS: The dog appeared healthy other than right-sided mucoid debris and decreased airflow through the right naris. The dog was anesthetized, and a large intranasal mass was observed obstructing the right nasal passage and abutting the nasal septum. TREATMENT AND OUTCOME: A lateral rhinotomy was performed, and rigid endoscopes (0° and 30°) were used to examine the right nasal cavity. The mass filled the anterior aspect of the nasal cavity and involved a portion of the nasal turbinates with some erosion. A coblation unit was used to ablate tumor tissue laterally to remove the tumor in piecemeal fashion. Recovery was routine with only minor epistaxis after surgery, and the dog was discharged the next day. Eight months after surgery, follow-up CT revealed right-sided nasal turbinate and conchal atrophy consistent with prior mass ablation. No macroscopic recurrence was detected, and the owners reported only rare, clear rhinorrhea. CLINICAL RELEVANCE: Findings suggested that coblation may be an alternative to radiation therapy for vascular tumors with minimal invasion and low metastatic potential.
Assuntos
Doenças do Cão , Hamartoma , Neoplasias Nasais , Animais , Doenças do Cão/cirurgia , Cães , Epistaxe/veterinária , Feminino , Hamartoma/cirurgia , Hamartoma/veterinária , Recidiva Local de Neoplasia/veterinária , Neoplasias Nasais/cirurgia , Neoplasias Nasais/veterinária , Conchas Nasais/cirurgiaAssuntos
Condrossarcoma/veterinária , Meios de Contraste/administração & dosagem , Doenças do Cão/diagnóstico por imagem , Epistaxe/veterinária , Infecções por Escherichia coli/veterinária , Iohexol/administração & dosagem , Infecções Urinárias/veterinária , Animais , Condrossarcoma/diagnóstico por imagem , Doenças do Cão/urina , Cães , Epistaxe/diagnóstico por imagem , Escherichia coli/isolamento & purificação , Infecções por Escherichia coli/diagnóstico por imagem , Infecções por Escherichia coli/urina , Masculino , Cavidade Nasal/diagnóstico por imagem , Cavidade Nasal/patologia , Concentração Osmolar , Gravidade Específica/efeitos dos fármacos , Tomografia Computadorizada por Raios X/veterinária , Urinálise/veterinária , Infecções Urinárias/diagnóstico por imagem , Infecções Urinárias/urina , Urina/química , Urina/microbiologiaRESUMO
BACKGROUND: Malignant fibrous histiocytoma has been uncommonly described in dogs. Several extranasal neoplasias have been reported to result hypertensive epistaxis. There are, however, no published case reports of extranasal malignant fibrous histiocytoma with concurrent hypertension and epistaxis in dogs. CASE PRESENTATION: A 10-year-old dog presented with a spontaneous massive epistaxis persisting for 5 days. The dog exhibited unstable hypertension, which was considered as a cause of epistaxis. The complete blood count, prothrombin time, and activated partial thromboplastin time were within the reference limits, and other systemic examination showed no abnormalities except for a splenic mass occupying more than one third of the abdomen. Histologic examination of the resected spleen revealed the characteristic features of a malignant fibrous histiocytoma. One week after splenectomy, the hypertension and epistaxis resolved clinically and did not recur on the 5-month follow-up. CONCLUSIONS: The dog's blood pressure and epistaxis normalized after malignant fibrous histiocytoma resection suggesting that hypertensive epistaxis may be a rare manifestation of canine malignant fibrous histiocytoma.
Assuntos
Doenças do Cão/diagnóstico , Epistaxe/veterinária , Histiocitoma Fibroso Maligno/veterinária , Hipertensão/veterinária , Neoplasias Esplênicas/veterinária , Animais , Doenças do Cão/patologia , Cães , Epistaxe/etiologia , Feminino , Histiocitoma Fibroso Maligno/complicações , Histiocitoma Fibroso Maligno/diagnóstico , Histiocitoma Fibroso Maligno/patologia , Hipertensão/etiologia , Baço/patologia , Neoplasias Esplênicas/complicações , Neoplasias Esplênicas/diagnóstico , Neoplasias Esplênicas/patologia , Tomografia Computadorizada por Raios X/veterináriaAssuntos
Doenças dos Cavalos/diagnóstico , Linfoma de Células T/veterinária , Animais , Autopsia/veterinária , Diagnóstico Diferencial , Epistaxe/etiologia , Epistaxe/veterinária , Doenças dos Cavalos/sangue , Doenças dos Cavalos/patologia , Cavalos , Humanos , Linfoma de Células T/complicações , Linfoma de Células T/diagnóstico , MasculinoAssuntos
Doenças do Cão/diagnóstico , Mastócitos , Neoplasias Nasais/veterinária , Neoplasias Faríngeas/veterinária , Animais , Doenças do Cão/patologia , Cães , Epistaxe/complicações , Epistaxe/veterinária , Feminino , Neoplasias Nasais/diagnóstico , Neoplasias Nasais/patologia , Neoplasias Nasais/fisiopatologia , Neoplasias Faríngeas/diagnóstico , Neoplasias Faríngeas/patologia , Neoplasias Faríngeas/fisiopatologiaRESUMO
The incidence of race-day injuries in Great Britain (GB) is higher on all-weather (AW) surfaces than on turf. However, to date no studies have focused on identifying risk factors for injury specific to AW racing. Therefore, the objective of the current study was to determine risk factors for fatality, distal limb fracture (DLF) and episodes of epistaxis in flat racing Thoroughbreds racing on AW surfaces in GB. Data included all flat racing starts on AW surfaces (n=258,193) and race-day veterinary events recorded between 2000 and 2013. Information on additional course-level variables was gathered during face-to-face interviews with racecourse clerks. Horse-, race- and course-level risk factors for each outcome were assessed using mixed-effects multivariable logistic regression including horse as a random effect. A classification tree method was used to identify potential interaction terms for inclusion in the models. During the study period, there were 233 fatalities resulting in a fatality incidence of 0.90 per 1000 starts; 245 DLF with a resultant DLF incidence of 0.95 per 1000 starts and 410 episodes of epistaxis resulting in an epistaxis incidence of 1.59 per 1000 starts. Risk factors varied for each outcome, although some factors were similar across models including the going, racing intensity, horse age, age at first race start, horse and trainer performance variables. Generally, older horses and those that had started racing at an older age were at higher risk of an adverse outcome, albeit with an interaction between the two variables in the fatality model. Faster going increased the odds of epistaxis and DLF but not fatality. Increasing race distance increased the odds of fatality but reduced the odds of epistaxis. Epistaxis was associated with type of AW surface (Fibresand versus Polytrack®), but DLF and fatality were not. This study provides further evidence of the association between the risk of race-day injuries and fatalities and current age, age at first start, race distance, going and horse performance. These findings provide the racing industry with information to develop strategies to reduce the occurrence of race-day events on AW surfaces.
Assuntos
Epistaxe/veterinária , Fraturas Ósseas/veterinária , Doenças dos Cavalos/epidemiologia , Cavalos/lesões , Mortalidade , Condicionamento Físico Animal/efeitos adversos , Animais , Epistaxe/etiologia , Feminino , Fraturas Ósseas/epidemiologia , Fraturas Ósseas/etiologia , Doenças dos Cavalos/etiologia , Incidência , Masculino , Fatores de Risco , Esportes , Reino Unido/epidemiologiaRESUMO
BACKGROUND: Tuberculosis caused by Mycobacterium bovis (M. bovis) is very uncommon in horses worldwide. CASE PRESENTATION: In the current study, an eight-year-old male Thoroughbred in good body condition was admitted to the Equine Clinic at the Onderstepoort Veterinary Academic Hospital in 2005 due to bilateral epistaxis accompanied by coughing. Routine examinations were conducted to determine the cause of the condition. Endoscopic examination revealed the major source of the epistaxis as the trachea, whereas thoracic radiography indicated the presence of a primary pulmonary mass. M. bovis was isolated from a broncho-alveolar lavage (BAL) sample collected. The pulmonary mass reduced in size three months later following an oral administration of enrofloxacin (7.5 mg/kg PO SID). Genetic fingerprinting by spoligotyping identified the M. bovis isolate as spoligotype SB0868 strain. This M. bovis strain type was never described previously in South Africa (SA). This is the first case of M. bovis infection in a horse in SA which has been fully documented including clinical findings, isolation and genetic characterisation of the causative pathogen. CONCLUSIONS: This report indicates that horses may contract and harbour M. bovis despite their lower susceptibility compared to other domestic animals. It also suggests that the infection may be more easily contained and eliminated from the host.
Assuntos
Epistaxe/veterinária , Doenças dos Cavalos/microbiologia , Mycobacterium bovis/genética , Mycobacterium bovis/isolamento & purificação , Tuberculose Pulmonar/veterinária , Animais , Líquido da Lavagem Broncoalveolar/microbiologia , Enrofloxacina , Epistaxe/diagnóstico por imagem , Epistaxe/tratamento farmacológico , Epistaxe/microbiologia , Fluoroquinolonas/uso terapêutico , Doenças dos Cavalos/tratamento farmacológico , Cavalos , Masculino , Tipagem Molecular/veterinária , Mycobacterium bovis/classificação , Radiografia Torácica/veterinária , Resultado do Tratamento , Tuberculose Pulmonar/diagnóstico por imagem , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/microbiologiaRESUMO
The objective of the study was to evaluate the effect of ligation of the ipsilateral common carotid artery (CCA) combined with various antimycotic treatments for the prevention of epistaxis in horses with guttural pouch mycosis. For each case, ipsilateral ligation of the CCA was performed, followed by application of various topical medications under endoscopic guidance. Frequency and number of treatments, outcome and recurrence of haemorrhage were retrospectively recorded. Twenty-four horses were included. Topical medication was administered by detachment of the diphtheric membrane and spraying (n=16) or by intralesional injection directly in the plaques using a transendoscopic needle (n=8). Epistaxis recurred in five horses (20.8 per cent), causing death of four horses (16.6 per cent). The mean number of treatments was 6.3±4.0 (range 2-14) for all topical treatments. Ligation of the ipsilateral CCA and topical medication carries a fair prognosis for avoidance of recurrent episodes of epistaxis, but fatal haemorrhage can occur. Removal of the fungal plaque and topical treatment of the underlying lesion appeared to speed up resolution of the mycotic mucosal lesions. The described technique is a salvage procedure when financial or technical constraints prevent the use of transarterial catheter occlusion techniques.
Assuntos
Antibacterianos/uso terapêutico , Artéria Carótida Primitiva/cirurgia , Epistaxe/veterinária , Doenças dos Cavalos/prevenção & controle , Micoses/veterinária , Administração Tópica , Animais , Epistaxe/prevenção & controle , Feminino , Cavalos , Ligadura/veterinária , Masculino , Micoses/tratamento farmacológico , Resultado do TratamentoRESUMO
A 7-year-old, spayed female Shetland sheepdog had sudden onset of right-sided epistaxis. Diagnostic tests revealed Type III von Willebrand's disease and primary hypothyroidism leading to an acute hypothyroid crisis and acquired factor VIII (FVIII) deficiency. Levothyroxine therapy normalized the serum thyroxine and FVIII concentrations. The delayed onset of disease and the reversible FVIII deficiency that was corrected with levothyroxine therapy, support a role for hypothyroidism in the pathogenesis of this dog's sudden bleeding tendency as has been seen with hypothyroidism in humans.
Maladie de Willebrand congénitale de type III mise au jour par l'hypothyroïdisme chez une chienne berger Shetland. Une chienne Shetland stérilisée âgée de 7 ans a manifesté l'apparition soudaine d'épistaxis du côté droit. Des tests diagnostiques ont révélé la maladie de von Willebrand de type III et l'hypothyroïdisme primaire provoquant une crise d'hypothyroïdisme aiguë et une déficience du facteur acquis VIII (FVIII). Une thérapie à la lévothyroxine a normalisé la thyroxine sérique et les concentrations de FVIII. L'apparition tardive de la maladie et la déficience réversible de FVIII, qui a été corrigée à l'aide de thérapie à la lévothyroxine, militent en faveur du rôle de l'hypothyroïdisme dans la pathogénèse de la tendance soudaine aux saignements de la chienne, comme nous l'observons dans l'hypothyroïdisme chez les humains.(Traduit par Isabelle Vallières).
Assuntos
Doenças do Cão/diagnóstico , Hipotireoidismo/veterinária , Doença de von Willebrand Tipo 3/veterinária , Animais , Doenças do Cão/etiologia , Doenças do Cão/patologia , Cães , Epistaxe/etiologia , Epistaxe/veterinária , Fator VIII , Feminino , Hipotireoidismo/complicações , Hipotireoidismo/tratamento farmacológico , Tiroxina/uso terapêutico , Doença de von Willebrand Tipo 3/complicações , Doença de von Willebrand Tipo 3/diagnóstico , Doença de von Willebrand Tipo 3/patologiaRESUMO
We report the case of a 4-year-old, castrated 4.2-kg Scottish fold cat with recurrent epistaxis that was unresponsive to medical therapy. Diathermocoagulation of the nasal mucosa with a diode laser controlled the epistaxis and there was no significant recurrence of epistaxis during 1 year of follow-up.
Coagulation à la diode laser pour le traitement de l'épistaxis chez un chat Scottish Fold. Nous signalons le cas d'un chat Scottish Fold castré âgé de 4 ans d'un poids de 4,2 kg atteint d'épistaxis récurrente qui n'a pas répondu au traitement médical. La diathermocoagulation de la muqueuse nasale à l'aide d'une diode laser a contrôlé l'épistaxis et il n'y pas eu de récurrence de l'épistaxis durant le suivi d'un an.(Traduit par Isabelle Vallières).
Assuntos
Doenças do Gato/terapia , Epistaxe/veterinária , Terapia a Laser/veterinária , Lasers Semicondutores/uso terapêutico , Animais , Gatos , Epistaxe/terapia , Terapia a Laser/métodos , MasculinoRESUMO
The aim of this study was to evaluate risk factors associated with developing epistaxis in jump racing in Great Britain (GB). A retrospective analysis of records from horses running in all hurdle and steeplechase races in GB between 2001 and 2009 identified diagnoses of epistaxis whilst still at the racecourse. Data were used from 603 starts resulting in epistaxis (event) and 169,065 starts resulting in no epistaxis (non-event) in hurdle racing, and from 550 event starts and 102,344 non-event starts in steeplechase racing. Two multivariable logistic regression models to evaluate risk factors associated with epistaxis were produced. The potential effect of clustering of data (within horse, horse dam, horse sire, trainer, jockey, course, race and race meet) on the associations between risk factors and epistaxis was examined using mixed-effects models. Multiple factors associated with increased risk of epistaxis were identified. Those identified in both types of jump racing included running on firmer ground; horses with >75% of career starts in flat racing and a previous episode of epistaxis recorded during racing. Risk factors identified only in hurdle racing included racing in the spring and increased age at first race; and those identified only in steeplechase racing included running in a claiming race and more starts in the previous 3-6 months. The risk factors identified provide important information about the risk of developing epistaxis. Multiple avenues for further investigation are highlighted, including unmeasured variables at the level of the racecourse. The results of this study can be used to guide the development of interventions to minimise the risk of epistaxis in jump racing.
Assuntos
Epistaxe/veterinária , Doenças dos Cavalos/etiologia , Corrida , Animais , Epistaxe/etiologia , Epistaxe/prevenção & controle , Feminino , Cavalos , Humanos , Modelos Logísticos , Masculino , Estudos Retrospectivos , Fatores de Risco , Esportes , Reino UnidoRESUMO
OBJECTIVE: To (1) describe ultrasound-guided percutaneous introduction of a transarterial angiographic catheter into the common carotid artery (CCA); (2) investigate the feasibility of using angiography of the carotid arteries in the guttural pouch region and assess transarterial coil (TAC) placement into the internal carotid artery (ICA). STUDY DESIGN: Experimental study. ANIMALS: Healthy Standardbred horses (n = 6), aged 5-8 years. METHODS: Six horses had ultrasound-guided percutaneous CCA catheterization and angiography under general anesthesia. Catheterization sites were ultrasonographically evaluated postoperatively. Ten weeks later using the same horses sedated and standing, the same procedure was combined with placement of a TAC in the ICA. RESULTS: Agitated contrast ultrasonography confirmed successful catheterization of the CCA. Needle puncture and introducer-set penetration of the CCA were the main technical difficulties. Radiography and fluoroscopy confirmed successful angiography and TAC placement. Mild hematoma formation was recorded in 4 of 12 procedures. CONCLUSION: Angiography and TCA placement in the ICA can be safely performed using a percutaneous approach to the CCA under ultrasound guidance, in standing or anesthetized horses. This approach might be used for TAC embolization procedure; however, technical difficulties and hematoma formation can impair the procedure.
Assuntos
Cateterismo/veterinária , Embolização Terapêutica/veterinária , Epistaxe/veterinária , Micoses/veterinária , Angiografia/métodos , Angiografia/veterinária , Animais , Artéria Carótida Primitiva , Cateterismo/métodos , Embolização Terapêutica/métodos , Epistaxe/diagnóstico por imagem , Epistaxe/cirurgia , Cavalos , Micoses/diagnóstico por imagem , Micoses/cirurgia , Postura , Ultrassonografia de Intervenção/métodos , Ultrassonografia de Intervenção/veterináriaRESUMO
OBJECTIVES: To assess ultrasound guided transarterial coil placement (UGTACP) for occlusion of the internal carotid artery (ICA) and external carotid artery (ECA) in horses. STUDY DESIGN: Cadaveric and in vivo study. ANIMALS: Cadaveric horses (n = 10), healthy horses (3), and 1 clinical case. METHODS: Cadaveric and in vivo (healthy horses): UGTACP was performed in the caudal part of the ICA and ECA. Coil placement in the rostral part of the ICA was performed blindly and controlled by conventional radiography. No coils were placed in the rostral part of the ECA. CLINICAL CASE: UGTACP of the ICA was in a horse with guttural pouch mycosis of the left guttural pouch. RESULTS: Accurate ultrasound-guided catheterization of the ICA and ECA was performed in all specimens. Ultrasound-guided coil placement was successfully performed in all cases except 1. No complications occurred in the in vivo study. The clinical case fully recovered and returned to its intended use. CONCLUSIONS: Based on our study, UGTACP of the ICA and ECA caudal part is a feasible alternative to fluoroscopy. An advantage of this technique is the accuracy with which you can catheterize both ICA and ECA and the ability to identify unusual branching at the origin of the ICA. Regarding the rostral part of the ICA, angiographic catheter guidance in this region is probably more precise using fluoroscopy as it is performed blindly. In a clinical situation, combination of US and fluoroscopy guidance can result in reduction of radiation exposure time.